Peter Greenleaf, CEO at Sucampo Pharmaceuticals, Inc. (SCMP), sold 82,459 shares at $16.75 ($1.4M) on 2016-11-29, disclosed to the SEC on 2016-11-30.
Open-market sale of $1.4M SCMP by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AUPH | SELL | 2025-03-04 | $4.2M | — | Filing → |
| AUPH | SELL | 2024-03-07 | $1.4M | — | Filing → |
| AUPH | SELL | 2024-02-22 | $580K | — | Filing → |